| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |